首页> 外文期刊>British Journal of Cancer >Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
【24h】

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

机译:抵抗去势抵抗性前列腺癌中循环微RNA生物标志物的2期研究

获取原文
           

摘要

Background:Biomarkers of therapeutic response and prognosis are needed to assist in the sequencing of treatments for metastatic castration-resistant prostate cancer (CRPC). Previously in a Phase 1 discovery study, we identified 14 circulating microRNAs that were associated with response to docetaxel chemotherapy or overall survival. We performed a Phase 2 validation study to verify these findings.
机译:背景:需要治疗反应和预后的生物标志物来协助对转移性去势抵抗性前列腺癌(CRPC)的治疗进行测序。先前在1期发现研究中,我们确定了14种循环微RNA与多西他赛化疗或总体生存相关。我们进行了2期验证研究,以验证这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号